Medcaptain Medical Technology Co. Ltd.HKEX: 2041

Medcaptain Medical Technology Shares Fall in Hong Kong Trading Debut

· Issued by Medcaptain Medical Technology Co. Ltd.

Summary by 6ix AI

Shares of Medcaptain Medical Technology, a Shenzhen-based medical-device provider, fell in their Hong Kong trading debut on Monday, September 7, 2026, dropping as much as 35% in early trading from the initial public offering (IPO) price of HK$15.42 to HK$9.99.

Key details

  • The shares were also reported down 31% from the IPO price at HK$10.63, and after the early low the stock pared losses to trade at HK$10.24.
  • Medcaptain raised HK$600 million, equivalent to US$76.5 million, by selling 38.9 million shares at HK$15.42 each.
  • The 3.9 million shares offered to the Hong Kong public were more than 436 times subscribed, meaning investors asked for more than 436 times the shares on offer, while the remaining shares in the international offering were 2.35 times subscribed.
  • The company makes medical products for areas including life support and in vitro diagnostics (tests done on samples such as blood outside the body).
  • Medcaptain aims to use the net proceeds to boost research and development, expand its product lines and increase production capacity.

6ix AI wrote this summary from the release below and checked it against the release.

(01:30 GMT) *Medcaptain Medical Technology Shares Fall 31% to HK$10.63 From IPO Price in Hong Kong Trading Debut (02:21 GMT) Medcaptain Medical Technology Shares Fall in Hong Kong Trading Debut

By Megan Cheah

Shares of Medcaptain Medical Technology declined in their Hong Kong trading debut on Monday, adding to the streak of lackluster debuts in the world's busiest venue for new offerings this year.

The stock shed as much as 35% from its initial-public offering price to trade at 9.99 Hong Kong dollars in early trading. It has since pared gains to trade at HK$10.24.

The Shenzhen-based medical-device provider raised HK$600 million, equivalent to US$76.5 million, through the sale of 38.9 million shares at HK$15.42 each.

The 3.9 million shares offered to the Hong Kong public was more than 436 times subscribed, while the remaining shares under the international offering were 2.35 times subscribed.

The company manufactures medical products for areas including life support and in vitro diagnostics. Medcaptain aims to use the net proceeds to boost its research and development, expand its product lines and increase its production capacity.

It is the first of three planned Hong Kong listings this week, with Shenzhen Longsys Electronics set to list Tuesday and Excelland Robotics scheduled to start trading on Wednesday.

Last week, shares of Shein fell as much as 10% on their first day of trading in Hong Kong before rebounding to close to the initial public offering price, while Mech-Mind declined on its first trading day.

Funds raised through IPOs in the first eight months of the year totaled HK$342.4 billion, more than double the amount raised in the same period a year earlier, data from Hong Kong Exchanges & Clearing showed.

Write to Megan Cheah at [email protected]

Medcaptain Medical Technology Co. Ltd. on 6ix

Earlier from Medcaptain Medical Technology

Later from Medcaptain Medical Technology

All Medcaptain Medical Technology news releases